Asked by: Paul Beresford (Conservative - Mole Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the waiting times for referral for atopic eczema patients on patient access to treatment; and what plans his Department has taken to reduce such waiting times in dermatology services.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
No formal assessment has been made.
Asked by: Paul Beresford (Conservative - Mole Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what impact assessment has been undertaken of the effect of covid-19 on the provision of NHS dermatology services.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
There has been no central formal impact assessment. Local systems delivering dermatology services carry out their own assessments.
Asked by: Paul Beresford (Conservative - Mole Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when his Department plans to develop (a) national clinical guidelines and (b) quality standards for the management of atopic eczema in adults and adolescents.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
The National Institute for Health and Care Excellence (NICE) is the independent, expert body responsible for developing authoritative, evidence-based guidance for the National Health Service. NICE has received a referral from NHS England and NHS Improvement to develop a guideline on atopic dermatitis or eczema in those aged over 12 years old, which will be commissioned for development in due course. There are no plans for NICE to develop a quality standard on atopic dermatitis in those aged over 12 years old.
Asked by: Paul Beresford (Conservative - Mole Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the proposal in his Department's Integration and innovation White Paper for a Secretary of State duty to publish a report every Parliament to support workforce planning responsibilities, whether he plans to include an audit of clinical nurse specialists who work in prostate cancer in that report.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
There is no plan for this duty to entail undertaking an audit in relation to clinical nurse specialists working in prostate cancer, nor any other health professions or medical conditions.
Asked by: Paul Beresford (Conservative - Mole Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has plans to undertake an audit of the prostate cancer workforce prior to the next iteration of the NHS People Plan.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
The Department does not hold information on the number of clinical nurse specialists who specialise in urology and prostate cancer who plan to retire in the next 12 months. No audit has been undertaken an audit of the clinical nurse specialist workforce for either urology or prostate cancer.
We are working with NHS England and NHS Improvement, Health Education England and employers to determine our future workforce and people priorities which will inform the NHS People Plan and future workforce planning requirements in key areas such as cancer. In 2021/22 Health Education England is offering training grants for up to 250 nurses to become cancer nurse specialists and up to 100 nurses to become chemotherapy nurse specialists.
Asked by: Paul Beresford (Conservative - Mole Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has undertaken an audit of the clinical nurse specialist workforce for (a) urology and (b) prostate cancer.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
The Department does not hold information on the number of clinical nurse specialists who specialise in urology and prostate cancer who plan to retire in the next 12 months. No audit has been undertaken an audit of the clinical nurse specialist workforce for either urology or prostate cancer.
We are working with NHS England and NHS Improvement, Health Education England and employers to determine our future workforce and people priorities which will inform the NHS People Plan and future workforce planning requirements in key areas such as cancer. In 2021/22 Health Education England is offering training grants for up to 250 nurses to become cancer nurse specialists and up to 100 nurses to become chemotherapy nurse specialists.
Asked by: Paul Beresford (Conservative - Mole Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of clinical nurse specialists who specialise in (a) urology and (b) prostate cancer who plan to retire in the next 12 months.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
The Department does not hold information on the number of clinical nurse specialists who specialise in urology and prostate cancer who plan to retire in the next 12 months. No audit has been undertaken an audit of the clinical nurse specialist workforce for either urology or prostate cancer.
We are working with NHS England and NHS Improvement, Health Education England and employers to determine our future workforce and people priorities which will inform the NHS People Plan and future workforce planning requirements in key areas such as cancer. In 2021/22 Health Education England is offering training grants for up to 250 nurses to become cancer nurse specialists and up to 100 nurses to become chemotherapy nurse specialists.
Asked by: Paul Beresford (Conservative - Mole Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what evidential threshold will be used when reviewing the travel status of countries under the new traffic light system.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
Travel status decisions are taken by Ministers informed by evidence including the Joint Biosecurity Centre’s analysis as well as other relevant information about the risk of the spread of variant. The advice, evidence and methodology which informs these decisions relates to on-going development of Government policy and therefore cannot be published at this time.